Patterson Companies (PDCO)
(Delayed Data from NSDQ)
$21.05 USD
+0.25 (1.20%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $21.05 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$21.05 USD
+0.25 (1.20%)
Updated Nov 11, 2024 04:00 PM ET
After-Market: $21.05 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
Zacks News
PDCO or CNMD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PDCO vs. CNMD: Which Stock Is the Better Value Option?
Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio
by Zacks Equity Research
Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.
Abbott (ABT) to Commence Limited Release of EleCare Soon
by Zacks Equity Research
Abbott's (ABT) release of limited quantities of EleCare branded specialty formulas to be free of charge to children in need.
Catalent's (CTLT) Latest Facility Expansion to Boost Capacity
by Zacks Equity Research
Catalent's (CTLT) latest site expansion is expected to significantly boost its business.
Reasons to Retain Catalent (CTLT) Stock in Your Portfolio
by Zacks Equity Research
Catalent's (CTLT) robust facility expansion activities and a slew of strategic deals raise optimism on the stock.
Reasons to Retain DaVita (DVA) Stock in Your Portfolio For Now
by Zacks Equity Research
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care and impressive overseas growth.
Catalent's (CTLT) New Launch to Enhance Gene Therapy Development
by Zacks Equity Research
Catalent's (CTLT) latest launch is expected to provide a reliable, reproducible and scalable path to clinic to its customers.
Reasons to Add Patterson Companies (PDCO) Stock to Your Portfolio
by Zacks Equity Research
Investors remain optimistic about Patterson Companies (PDCO) on the back of its strong product line.
AMN Healthcare's (AMN) New Buyout to Aid Healthcare Staffing
by Zacks Equity Research
AMN Healthcare's (AMN) acquisition of Connetics USA is expected to significantly boost its Nurse and Allied Solutions segment globally.
Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now
by Zacks Equity Research
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.
PDCO vs. CNMD: Which Stock Is the Better Value Option?
by Zacks Equity Research
PDCO vs. CNMD: Which Stock Is the Better Value Option?
Has Amphastar Pharmaceuticals (AMPH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Amphastar Pharmaceuticals (AMPH) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.
PDCO or CNMD: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PDCO vs. CNMD: Which Stock Is the Better Value Option?
Here's Why You Should Retain Allscripts (MDRX) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about Allscripts Healthcare Solutions (MDRX) owing to its strategic alliances.
Here's Why You Should Retain Baxter (BAX) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio and regulatory clearances.
Here's Why You Should Retain Cardinal Health (CAH) Stock Now
by Zacks Equity Research
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversified product portfolio. However, contraction in gross margin is a woe.
Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio
by Zacks Equity Research
Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.
Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now
by Zacks Equity Research
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woes persist.
Fast-paced Momentum Stock Patterson Cos. (PDCO) Is Still Trading at a Bargain
by Zacks Equity Research
Patterson Cos. (PDCO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Patterson Companies (PDCO) Moves Up 12.5%: What's Driving It?
by Zacks Equity Research
Investors are optimistic about Patterson Companies' (PDCO) robust segmental performance and strong prospects in the dental space.
Has Owens & Minor (OMI) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Owens & Minor (OMI) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.
Acadia Healthcare (ACHC) Up 10% in 3 Months: More Room to Run?
by Zacks Equity Research
Solid demand for behavioral healthcare services, multiple growth-related initiatives and a solid cash balance are driving Acadia Healthcare (ACHC).
Here's Why You Should Invest in Patterson Companies (PDCO) Stock
by Zacks Equity Research
Patterson Companies (PDCO) continues to benefit from strength in the Animal Health business and dental business.
Here's Why You Should Retain ShockWave Medical (SWAV) Stock
by Zacks Equity Research
ShockWave Medical (SWAV) continues to benefit from solid R&D efforts and commitment toward clinical studies. However, limited commercial expertise is a woe.
Here's Why You Should Buy McKesson (MCK) Stock Right Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.